Investigating risk factors in patients with acute coronary syndrome undergoing a procedure

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to recruit patients diagnosed with acute coronary syndrome who are undergoing percutaneous coronary intervention. Participants will be followed for at least two years to monitor the incidence of major adverse cardiovascular events, including mortality and ischemic stroke. Blood and fecal samples will be collected for further analysis, alongside comprehensive clinical data such as medical history and treatment methods. The study seeks to identify risk factors that influence the occurrence and prognosis of acute coronary syndrome.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed as acute coronary syndrome and needed to undergo percutaneous coronary intervention.
* \>18 years old.

Exclusion Criteria:

* With malignant tumors, acute infectious diseases and advanced liver diseases.
* Won't sign an inform consent.

Where it's running

• Jinan Central Hospital
  Jinan, Shandong, China Recruiting

Study contacts

• Principal investigator: Guohao Su, doctor — Jinan Central Hospital
• Study coordinator: Guohai Su, doctor
• Email: huangrong9277@163.com
• Phone: +86-18854125717

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry collecting data on patients undergoing heart artery procedures

  This study is collecting information from patients who are having heart artery procedures to see how they do during and after their treatment.

  Recruiting Federico II University · Naples · NCT05248165

• Comparing a new medication to standard treatment for preventing stomach issues in heart patients on blood thinners

  This study is testing a new medication called tegoprazan to see if it can prevent stomach problems just as well as the standard treatment for heart patients who are taking blood thinners.

  Recruiting at 36 sites Phase 4 Asan Medical Center · Anyang and 44 other locations · NCT04416581

• Registry for patients undergoing angioplasty in Korea

  This study is collecting information from patients who have had angioplasty to help understand how well the treatment works in real life.

  Recruiting Yonsei University · Seoul · NCT03908463

• Registry of patients with coronary artery issues and platelet test results

  This study collects information from patients with coronary artery disease to see how well their blood-thinning medications work and to find the best treatment options for them.

  Recruiting Action, France · Paris · NCT02762162

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Comparing two types of drug-coated stents for patients at high bleeding risk

  This study is testing if a new type of drug-coated stent is just as good and safe as a standard one for people with coronary artery disease who are at high risk of bleeding.

  Recruiting at 6 sites Biosensors Europe SA · Johor Bahru, Johor and 5 other locations · NCT06657326

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.